Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:1074-1079, 2006
DOI: 10.2337/diabetes.55.04.06.db05-1109
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiang, A. H.
Right arrow Articles by Buchanan, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiang, A. H.
Right arrow Articles by Buchanan, T. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Coordinate Changes in Plasma Glucose and Pancreatic ß-Cell Function in Latino Women at High Risk for Type 2 Diabetes

Anny H. Xiang1, Chengwei Wang1, Ruth K. Peters1, Enrique Trigo2, Siri L. Kjos3, and Thomas A. Buchanan2,3

1 Department of Preventive Medicine, University of Southern California School of Medicine, Los Angeles, California
2 Department of Medicine, University of Southern California School of Medicine, Los Angeles, California
3 Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles, California

Address correspondence and reprint requests to Thomas A. Buchanan, MD, Room 6602, General Hospital, 1200 N. State St., Los Angeles, CA 90033. E-mail: buchanan{at}usc.edu

Abbreviations: AIRg, acute insulin response to intravenous glucose; GDM, gestational diabetes mellitus; IVGTT, intravenous glucose tolerance test; OGTT, oral glucose tolerance test

The purpose of this study was to examine longitudinally the relationship among glucose levels, pancreatic ß-cell function, and insulin resistance in women at high risk for type 2 diabetes. Oral glucose tolerance tests (OGTTs) and intravenous glucose tolerance tests (IVGTTs) were performed at 15-month intervals for up to 5 years or until fasting plasma glucose exceeded 140 mg/dl in Hispanic women with recent gestational diabetes. Data were analyzed 1) to compare changes in insulin sensitivity, ß-cell function, and glucose levels between women who had diabetes at one or more visits and women who remained diabetes free and 2) to determine longitudinal patterns of change in glucose levels and acute ß-cell compensation for insulin resistance. Seventy-one women provided data from a total of 280 paired OGTTs and IVGTTs during a median follow-up of 46 months. Compared with the 47 women who remained free of diabetes, the 24 who either had diabetes (n = 9) or developed it during follow-up (n = 15) had higher baseline glucose levels and lower acute ß-cell compensation for insulin resistance. Baseline insulin sensitivity was low in both groups and did not change significantly during follow-up. Fasting and 2-h glucose levels increased more rapidly in the diabetic group despite a decline in acute ß-cell compensation that was significantly slower than the decline in women who did not develop diabetes. This paradox was explained by an accelerated rise in glucose levels for any decline in ß-cell compensation when ß-cell compensation reached ~10% of normal, a level that was reached in the women who had or developed diabetes but not in the women who remained diabetes free. These findings define a pathogenesis for type 2 diabetes in one high-risk group that is characterized by a relatively long-term decline in acute ß-cell compensation for chronic insulin resistance that is attended by slowly rising glucose levels. Only relatively late in this process do glucose levels rise rapidly and into the diabetic range.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
M. I. Goran, C. Lane, C. Toledo-Corral, and M. J. Weigensberg
Persistence of Pre-Diabetes in Overweight and Obese Hispanic Children: Association With Progressive Insulin Resistance, Poor {beta}-Cell Function, and Increasing Visceral Fat
Diabetes, November 1, 2008; 57(11): 3007 - 3012.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. E. Friedman, J. P. Kirwan, M. Jing, L. Presley, and P. M. Catalano
Increased Skeletal Muscle Tumor Necrosis Factor-{alpha} and Impaired Insulin Signaling Persist in Obese Women With Gestational Diabetes Mellitus 1 Year Postpartum
Diabetes, March 1, 2008; 57(3): 606 - 613.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. C. Mason, R. L. Hanson, and W. C. Knowler
Progression to Type 2 Diabetes Characterized by Moderate Then Rapid Glucose Increases
Diabetes, August 1, 2007; 56(8): 2054 - 2061.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
T. A. Buchanan, A. Xiang, S. L. Kjos, and R. Watanabe
What Is Gestational Diabetes?
Diabetes Care, July 1, 2007; 30(Supplement_2): S105 - S111.
[Full Text] [PDF]


Home page
DiabetesHome page
T. A. Buchanan
(How) Can We Prevent Type 2 Diabetes?
Diabetes, June 1, 2007; 56(6): 1502 - 1507.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Sakaue, S. Ishimaru, D. Ikeda, Y. Ohtsuka, T. Honda, J.-i. Suzuki, Y. Kawakami, J. Ishii, and M. Nishimura
Estimation of beta-cell function from the data of the oral glucose tolerance test
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1575 - E1580.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Cnop, J. Vidal, R. L. Hull, K. M. Utzschneider, D. B. Carr, T. Schraw, P. E. Scherer, E. J. Boyko, W. Y. Fujimoto, and S. E. Kahn
Progressive Loss of {beta}-Cell Function Leads to Worsening Glucose Tolerance in First-Degree Relatives of Subjects With Type 2 Diabetes
Diabetes Care, March 1, 2007; 30(3): 677 - 682.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Lim, S. H. Choi, Y. J. Park, K. S. Park, H. K. Lee, H. C. Jang, N. H. Cho, and B. E. Metzger
Visceral Fatness and Insulin Sensitivity in Women With a Previous History of Gestational Diabetes Mellitus
Diabetes Care, February 1, 2007; 30(2): 348 - 353.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. B. Davidson
Clinical Implications of the DREAM Study
Diabetes Care, February 1, 2007; 30(2): 418 - 420.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.